Related Experiment Video
Updated: Oct 18, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship With Cognitive
Melissa Lamar1,2, Sue Leurgans1,3, Alifiya Kapasi1,4
1Rush Alzheimer's Disease Center (M.L., S.L., A.K., L.L.B., P.A.B., D.A.B., K.A., J.A.S.), Rush University Medical Center, Chicago, IL.
Insights
Mixed cerebrovascular disease (CVD) profiles are more common and linked to faster cognitive decline than single CVD. Specific combinations of vessel disease and tissue injury differentially impact cognitive domains in dementia.
Area of Science:
- Neurology
- Pathology
- Gerontology
Background:
- Cerebrovascular disease (CVD) encompasses vessel diseases and tissue injury, contributing to Alzheimer's and other dementias.
- The interplay of various CVD combinations and their cognitive impact remains largely uncharacterized.
Purpose of the Study:
- To investigate the frequencies of 32 cerebrovascular disease (CVD) combinations.
- To determine the associations between these CVD combinations and cognitive decline.
Main Methods:
- Utilized autopsy data from 1474 decedents from Rush Alzheimer's Disease Center studies.
- Employed mixed-effect models to analyze 32 CVD combinations and their relationship with cognitive decline, adjusting for covariates.
Main Results:
- 80% of decedents had CVD; 63% exhibited mixed CVD profiles, compared to 37% with single CVD.
- Mixed CVD profiles were associated with significantly faster cognitive decline across all domains compared to no CVD.
- Specific mixed CVD combinations, particularly those with atherosclerosis and arteriolosclerosis, showed distinct associations with cognitive domains.
Conclusions:
- Mixed cerebrovascular disease (CVD) is more prevalent than single CVD and significantly associated with accelerated cognitive decline.
- Distinct combinations of CVD pathologies contribute heterogeneously to cognitive decline, impacting specific cognitive domains.
Background And Purpose:
Cerebrovascular disease (CVD) pathologies including vessel disease (atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy) and tissue injury (macroinfarcts and microinfarcts) each contribute to Alzheimer and other forms of dementia. CVD is often a complex mix of neuropathologies, with little known about the frequencies of differing combinations or their associations with cognition.
Methods:
We investigated 32 possible CVD combinations (3 types of vessel disease and 2 types of tissue injury) using autopsy data from 1474 decedents (≈88 years at death; 65% female) of Rush Alzheimer's Disease Center studies. We determined frequencies of all 32 CVD combinations and their relationships with global and domain-specific cognitive decline using mixed-effect models adjusted for demographics, neuropathologies, time before death, and interactions of these variables with time.
Results:
Of the 1184 decedents with CVD neuropathology (80% of the total sample), 37% had a single CVD (67-148 decedents/group) while 63% had mixed CVD profiles (11-54 decedents/group). When considered as 2 distinct groups, the mixed CVD profile group (but not the single CVD profile group) showed a faster cognitive decline across all domains assessed compared with decedents without CVD neuropathology. Most mixed CVD profiles, especially those involving both atherosclerosis and arteriolosclerosis, showed faster cognitive decline than any single CVD profile considered alone; specific mixed CVD profiles differentially associated with individual cognitive domains.
Conclusions:
Mixed CVD, more common than single CVD, is associated with cognitive decline, and distinct mixed CVD profiles show domain-specific associations with cognitive decline. CVD is not monolithic but consists of heterogenous person-specific combinations with distinct contributions to cognitive decline.
Related Concept Videos
Cognitive Development During Adulthood
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Pharmacodynamics in Geriatric Patients: Effects of Age
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Dementia
The progression of dementia is generally gradual....
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

